Replies to post #13429 on Kaival Brands Innovations Group Inc (KAVL)

[daiello]

Our day is coming as soon as they R/S and get us off this retail filled circus of an exchange.

We traded ~$200k today and we're down more than 10%. That is pathetic for a company that is doing what KAVL is doing.

People rather trade SEC delinquent stocks with billions of shares outstanding, instead of us. The NASD differentiates us, and if you think we're going to sustain a share price over $4 knowing and seeing everything we've been seeing lately, then you're being delusional and selfish.

I guarantee some of those selling are still concerned about an R/S, again, because OTC traders for whatever reason can't differentiate an R/S for additional dilution and an R/S to list on a reputable exchange and not stay in the shadows.

[Vipyr]

It absolutely still happens on Nasdaq. Its happening right now, the entire biotech sector is being shorted 98%. All because of what WSB did to GME. While all indexes continue to rise, all nano/mico/and small caps are being bled to death. As you said, different reasons, different tatics